Lendlease announces it's going to divest its engineering business

Construction and infrastructure business Lendlease Group (ASX:LLC) has announced that it's going to divest its Engineering business.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Lendlease Group (ASX: LLC) has announced that it has entered into an agreement with Acciona Infrastructure Asia Pacific to sell its Engineering business for a purchase price of $180 million.

The sale price is $180 million, but under the terms of the sales agreement Acciona will acquire the engineering business excluding the NorthConnex and Kingsford Smith Drive projects which will be completed by Lendlease, those projects are both in their final stages and are at least 90% complete.

The Melbourne Metro project is also currently excluded – the start of the project has been slower than anticipated, there have been issues in relation to the scope and costs on the project.

Group CEO and Managing Director Steve McCann said: "We believe the sale of the Engineering business represents a positive outcome for our people, our clients and our securityholders. Acciona is already a leader in the sector in which they operate. Our skilled workforce, client relationships and existing projects stand to enhance their existing footprint in Australia.

"Today's announcement also represents an important milestone Lendlease as we continue to focus on the successful delivery of our more than $100 billion global development pipeline."

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Broker Notes

What is this broker's view on Magellan Financial Group after yesterday's disappointing results

Where to next for this funds manager?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

This ASX industrials stock could be set to double according to one broker

This ASX small-cap could be one to keep an eye on.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Broker Notes

What's Bell Potter's updated view on CSL shares?

Will the new tariffs impact CSL according to Bell Potter?

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
BNPL shares

Are Zip shares still a buy after soaring 20%

Zip shares are now 67% higher than this time 12 months ago.

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Share Fallers

DroneShield shares tumble 17% as CEO exit revives leadership fears

Investors bank gains as DroneShield leadership reset unsettles sentiment...

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »